Unique ID issued by UMIN | UMIN000021572 |
---|---|
Receipt number | R000024875 |
Scientific Title | Biomarker research on the association between the effect and the HPV infection on the multimodal therapy for oropharyngeal squamous cell carcinoma |
Date of disclosure of the study information | 2016/03/23 |
Last modified on | 2024/04/19 22:01:04 |
Biomarker research on the association between the effect and the HPV infection on the multimodal therapy for oropharyngeal squamous cell carcinoma
Biomarker research on the HPV infection for oropharyngeal carcinoma
Biomarker research on the association between the effect and the HPV infection on the multimodal therapy for oropharyngeal squamous cell carcinoma
Biomarker research on the HPV infection for oropharyngeal carcinoma
Japan |
Oropharyngeal squamous cell carcinoma
Oto-rhino-laryngology |
Malignancy
YES
We research an association between the effect of the oropharyngeal squamous cell carcinoma and the HPV infection on the chemoradiotherapy
Efficacy
The efficacy of multimodal therapy and HPV infection for oropharyngeal carcinoma
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Gene |
chemotherapy, chemoradiotherapy
18 | years-old | <= |
80 | years-old | >= |
Male and Female
oropharyngeal squamous cell carcinoma
Stage III/IV
PS 0,1
No prior treatment
Patient with surgical treatment
Distant metastasis
Double cancer
213
1st name | Katsunari |
Middle name | |
Last name | Yane |
Kindai University Nara Hospital
Otorhinolaryngology
630-0293
1248-1,Otoda,Ikoma,nara
0743-77-0880
kyane@med.kindai.ac.jp
1st name | Katsunari |
Middle name | |
Last name | Yane |
Kindai University Nara Hospital
Otorhinolaryngology
630-0293
1248-1,Otoda,Ikoma,nara
0743-77-0880
kyane@med.kindai.ac.jp
The study group of basic research of the head and neck
Japan society for the promotion of science
Japanese Governmental office
Kindai University Nara Hospital
1248-1,Otoda,Ikoma,nara
0743-77-0880
ikyokujimu@med.kindai.ac.jp
NO
2016 | Year | 03 | Month | 23 | Day |
https://www.med.kindai.ac.jp/nara/departments_and_centers/other/irb/
Unpublished
https://www.med.kindai.ac.jp/nara/departments_and_centers/other/irb/
80
Among 80 samples, HPV positive oropharyngeal squamous cell carcinoma was 56 cases and HPV negative was 24 cases. Among HPV positive cases HPV16 was 49 cases, HPV35 was 3 cases respectively. In HPV positive samples, PIK3CA was the most common genomic alteration, the second one was FGFR3 and the third one was PTEN. In HPV negative samples, TP53 was most frequently altered. HPV positive patients had significantly better overall survival and disease free survival than HPV negative.
2024 | Year | 04 | Month | 19 | Day |
Patients with newly diagnosed oropharyngeal squamous cell carcinoma stage 3,4 and over 20 years old, performance status was from 0 to 2, treated with multimodal therapy mainly by chemo-radio therapy were registered.
The eighty samples were obtained in patients with previously untreated stage 3, 4 oropharyngeal squamous cell carcinoma who underwent multidisciplinary therapy at 14 Japanese hospitals that were the member of the Japan Cooperative Study Group for Basic Research in Head and Neck Cancer from May 2014 to March 2016.
No adverse event
Primary endpoint : overall survival
Secondary endpoint : disease-free survival
Completed
2015 | Year | 10 | Month | 01 | Day |
2015 | Year | 11 | Month | 30 | Day |
2016 | Year | 04 | Month | 01 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
Accompanying study of UMIN000013476
2016 | Year | 03 | Month | 22 | Day |
2024 | Year | 04 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024875